TY - JOUR
T1 - Identification of a dominant MYH11 causal variant in chronic intestinal pseudo-obstruction
T2 - Results of whole-exome sequencing
AU - Dong, Weilai
AU - Baldwin, Clinton
AU - Choi, Jungmin
AU - Milunsky, Jeff M.
AU - Zhang, Junhui
AU - Bilguvar, Kaya
AU - Lifton, Richard P.
AU - Milunsky, Aubrey
N1 - Funding Information:
We thank George Carbone MD for helping assemble the information and blood sampling from his extended family reported here. This work was supported by Center for Human Genetics Research Fund.
Publisher Copyright:
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
PY - 2019/11/1
Y1 - 2019/11/1
N2 - Chronic Intestinal Pseudo-Obstruction (CIPO) is a rare gastrointestinal disorder, which affects the smooth muscle contractions of the gastrointestinal tract. Dominant mutations in the smooth muscle actin gene, ACTG2, accounts for 44%-50% of CIPO patients. Other recessive or X-linked genes, including MYLK, LMOD1, RAD21, MYH11, MYL9, and FLNA were reported in single cases. In this study, we used Whole-Exome Sequencing (WES) to study 23 independent CIPO families including one extended family with 13 affected members. A dominantly inherited rare mutation, c.5819delC (p.Pro1940HisfsTer91), in the smooth muscle myosin gene, MYH11, was found in the extended family, shared by 7 affected family members but not by 3 unaffected family members with available DNA, suggesting a high probability of genetic linkage. Gene burden analysis indicates that additional genes, COL4A1, FBLN1 and HK2, may be associated with the disease. This study expanded our understanding of CIPO etiology and provided additional genetic evidence to physicians and genetic counselors for CIPO diagnosis.
AB - Chronic Intestinal Pseudo-Obstruction (CIPO) is a rare gastrointestinal disorder, which affects the smooth muscle contractions of the gastrointestinal tract. Dominant mutations in the smooth muscle actin gene, ACTG2, accounts for 44%-50% of CIPO patients. Other recessive or X-linked genes, including MYLK, LMOD1, RAD21, MYH11, MYL9, and FLNA were reported in single cases. In this study, we used Whole-Exome Sequencing (WES) to study 23 independent CIPO families including one extended family with 13 affected members. A dominantly inherited rare mutation, c.5819delC (p.Pro1940HisfsTer91), in the smooth muscle myosin gene, MYH11, was found in the extended family, shared by 7 affected family members but not by 3 unaffected family members with available DNA, suggesting a high probability of genetic linkage. Gene burden analysis indicates that additional genes, COL4A1, FBLN1 and HK2, may be associated with the disease. This study expanded our understanding of CIPO etiology and provided additional genetic evidence to physicians and genetic counselors for CIPO diagnosis.
KW - Chronic Intestinal Pseudo-Obstruction
KW - MYH11
KW - exome-sequencing
KW - genetics
UR - http://www.scopus.com/inward/record.url?scp=85070759634&partnerID=8YFLogxK
U2 - 10.1111/cge.13617
DO - 10.1111/cge.13617
M3 - Article
C2 - 31389005
AN - SCOPUS:85070759634
SN - 0009-9163
VL - 96
SP - 473
EP - 477
JO - Clinical Genetics
JF - Clinical Genetics
IS - 5
ER -